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A novel Pt(IV) mono azido mono triazolato
complex evolves azidyl radicals following
irradiation with visible light†
Kezi Yao,a Arnau Bertran,a Jacques Morgan,a Samuel M. Hare,a Nicholas H. Rees,a
Alan M. Kenwright, b Katharina Edkins, c Alice M. Bowen a and
Nicola J. Farrer *a
The platinum(IV) azido complex trans,trans,trans-[PtIV(N3)2(OH)2(py)2] (1) undergoes cycloaddition with
1,4-diphenyl-2-butyne-1,4-dione (2) under mild, catalyst-free conditions, aﬀording a number of mono
and bis click products. The major mono click product (3) exists in MeCN as an equilibrium mixture
between two species; 3a and 3b rapidly interconvert through nucleophilic attack of the axial Pt–OH
group at the adjacent Ph–CO group. The kinetic and thermodynamic parameters for this interconversion
have been measured by selective saturation-transfer NMR spectroscopic experiments and are consistent
with cyclisation at the Pt centre. Complex 3b was also characterised by X-ray crystallography. Visible light
irradiation (440–480 nm) of 3 in d3-MeCN produces azidyl radicals (N3
•), as demonstrated by EPR spin-
trapping with DMPO; no generation of hydroxyl radicals was observed. 1H–195Pt HMBC NMR conﬁrmed
that the photoproducts were PtIV rather than PtII species, and HPLC was consistent with these being [3–
N3]
+ species; no facile photoejection of the triazolato ligand was observed, consistent with MS/MS frag-
mentation of 3. When 3 was irradiated in the presence of 5’-GMP, no 5’-GMP photoproducts were
observed, suggesting that complex 3 is likely to exhibit signiﬁcantly simpliﬁed biological activity (release of
azidyl radicals but not DNA binding) compared with complex 1.
Introduction
Reactivity of metal azides towards acetylenes in a [3 + 2]
1,3-dipolar cycloaddition (or “click” reaction) to form triazoles
is a well-established route to form new metal complexes and
new ligands which are not readily accessible by other routes.1
Although [3 + 2] cycloadditions have been extensively investi-
gated in organic synthesis, the potential of cycloaddition reac-
tions of metal-coordinated ligands is less well-explored. To
date, click reactions between metal azides and alkynes
(or masked alkynes)2 have been used in a range of synthetic
investigations; forming Pt(II)–Au(I) heterometallic arrays,3 tri-
Au(I) triazoles,4 Ru-based catalysts5 and metalloenzyme inhibi-
tors.6 They have also been used to synthesise Au(I) triazole
peptide conjugates targeted to mitochondria, which showed
promising anti-cancer activity.7 The new triazole ligands
formed in these cycloaddition reactions themselves have a
wide-range of chemistries and potential applications.8 Whilst
copper(I)-catalysed (CuAAC) reactions dominate the literature,9
our focus is on copper-free cycloadditions, since the cyto-
toxicity of copper salts is undesirable for biological appli-
cations.10 We recently reported that trans,trans,trans-[Pt
(N3)2(OH)2(py)2] 1 is reactive towards a number of strained
cyclooctynes and highly electron-deficient acetylenes including
DMAD, but does not react with other acetylenes including phe-
nylpropiolic acid, 1-phenyl-2-propyn-1-ol and 3-butyn-2-one.11
We focused on internal alkynes, because terminal alkynes
(HCuCR) often undergo azide-acetylene ligand exchange with
metal azides, rather than 1,3-dipolar cycloaddition; for
example, cis-[Pt(N3)2(PPh3)2] reacts with acetylenylbenzene to
give trans-[Pt(CuCPh)2(PPh3)2].
12 Consequently, we investi-
gated the reactivity of the azido complex 1 towards the acety-
lene 1,4-diphenyl-2-butyne-1,4-dione (2) and here we report
our findings.
Although no Pt(II) or Pt(IV) examples have been previously
reported, acetylene 2 (Scheme 1) undergoes cycloadditions
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with both Pd(II)13 and Ni(II)14 mono azido complexes. For Pd
(II), the coordinated triazole ligand is not constrained through
additional cyclisation, and equivalent 1H NMR spectral reso-
nances for the Ph groups were observed, consistent with
rearrangement to N2 triazole coordination. For Ni(II), in
addition to triazole formation, one of the PhCO groups of the
triazole condensed with a ligand-based NH2 group, forming a
5-membered ring containing the Ni; the IR and 1H NMR
spectra indicated triazole formation and retention of N1-
coordination. It is generally accepted that the N1-bound tri-
azole isomer forms as the kinetic product of the cycloaddition
reaction. For metal-based cycloadditions – in contrast to purely
organic cycloadditions – this isomer may often then undergo
rearrangement to the more thermodynamically stable N2-
bound isomer.15 The N1/N2 coordination preference appears
to be a balance of sterics, electronics and any potential ligand
cyclisation which could “lock” the triazole in N1 coordination.
Small modifications in the ligands may alter the N1/N2 prefer-
ence; for the reaction of Ru-azido complexes with DMAD and
diethylacetylenedicarboxylate (DEACD), X-ray crystallography
confirmed a change in preference from N1 (ethyl) to N2
(methyl) triazole coordination depending on the ligand substi-
tuents for a number of Ru azido complexes.16,17
Since Pt(IV) azido groups are considerably less electron-rich
than Pt(II) azides they are anticipated to be even less amenable
to cycloaddition with electron-deficient acetylenes. We were
therefore surprised to observe the reaction of 2 with the PtIV
diazido complex 1 under mild conditions.
Results and discussion
After stirring a solution of 1 and 2 (1.1 eq.) in MeCN (35 °C, 2 d)
the reaction solution was concentrated under vacuum and fil-
tered. RP-HPLC (MeCN + 0.1% NH4OH/H2O + 0.1% NH4OH,
pH 9) purification of the filtrate revealed four new cycloaddition
products, three mono-substituted species; (tR = 4.01 min, 8%);
complex 3 (tR = 4.31 min, 73%); (tR = 5.44 min, 2%) and one
bis-substituted species (tR = 5.94 min, 7%) (Fig. S1†).
Complex 3 consists of interconverting isomers 3a and 3b
HPLC solvent was removed from the main product 3
(tR 4.3 min, 73%) by freeze-drying; yellow crystals were grown
by vapour diﬀusion of tetrahydropyran into a concentrated
MeCN solution of 3. Single crystal X-ray crystallography
revealed the structure of the mono-click product (3b) which
had cyclised via attack of the Pt–OH ligand at the PhCO group
to form a 5-membered ring (Fig. 1).
Both the azido (Pt–Nα–Nβ–Nγ) ligand angle and bond
lengths are very similar to those seen in the diazido precursor
complex; (174.8(6)° in 3b vs. 174.4(4)/175.3(4)° in 1);19 and
1.218(6)/1.215(4), 1.218(5), Å (Nα–Nβ) and 1.142(6)/1.139(4),
1.146(5) Å (Nβ–Nγ) in 3b and 1 respectively. The angle sub-
tended at Pt–Nα–Nβ is more acute for complex 3b (114.2(3)°)
compared to complex 1 (118.0(3)°, 120.3(2)°). The Pt–N1 tri-
azole bond length is 1.998(4) Å, which compared to reported
PtII N1-coordinated 1,4-disubstituted triazole complexes with
lengths of 2.149(2) Å–2.139(2) Å, is indicative of relatively
strong bonding.8,20
Although on re-injection for analytical HPLC, 3 eluted as a
single peak (tR = 4.40 min) (Fig. S2†), in d3-MeCN solution at
25 °C, 3 existed in dynamic equilibrium between two
isomers – 3a and 3b – in a 1 : 1 ratio. 1H and 13C NMR spectral
resonances of complexes 3a and 3b were fully characterised by
1D and 2D (COSY/ROESY/HSQC/HMBC) spectroscopic
techniques (Fig. S3†).
1H–195Pt HMBC NMR spectroscopy revealed two distinct
195Pt environments, for 3a (689 ppm) and 3b (785 ppm)
respectively (Fig. 2). Addition of D2O to the d3-MeCN NMR
sample resulted in the loss of the 3b C-OH 1H NMR spectral
resonance at 4.93 ppm, as a result of proton/deuterium
exchange. The equilibrium species 3a/3b were stable in d3-
MeCN (in the dark), for a period of at least 6 months.
Depending on the mass spectrometer, either Na+ or H+
adducts of 3 were also observed by ESI-MS; [(3)2 + Na]
+ was
detected at 1433.29 m/z and [3 + Na]+ at 728.14 m/z; and under
some conditions [3 + H]+ was detected at 706.15 m/z. The
[3–OH]+ adduct at 688.15 m/z was consistently observed on all
instruments (Fig. S4†). HRMS of 3 supported the identity of
both [3 + H]+ (706.1438 m/z) (Fig. S5†) and [3–OH]+ (688.1379
m/z) (Fig. S6†) species. MS/MS fragmentation of the [3 + H]+
species (706.15 m/z) revealed that it very readily fragmented to
give [3–OH]+ (688.14 m/z, C26H21N8O3Pt calc. 688.14 m/z) and
Scheme 1 Reaction of trans,trans,trans-[Pt(N3)2(OH)2(py)2] (1) with 1,4-
diphenyl-2-butyne-1,4-dione (2) showing formation of the major
product 3 (3a/3b).
Fig. 1 X-Ray crystallographic structure of 3b with thermal ellipsoids
displayed at 50% probability.18 Pt-Azido group naming convention;
N15 = Nα, N16 = Nβ and N17 = Nγ.
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also the [Pt(triazole)(py)(OH)]+ species (567.09 m/z,
C21H16N4O3Pt calc. 567.09 m/z) through loss of pyridine and
azide (where triazole = C16H10N3O2) (Fig. S4†).
The [3–triazole]+ fragment ([Pt(OH)2Py2(N3)]
+ ca. 429.06
m/z) was not observed, indicating that the triazole ligand does
not preferentially dissociate to give a stable charged species
without other ligands also being lost; however, smaller
fragments such as [Pt(OH)(py)2]
+ (370.0546 m/z, C10H11N2OPt,
calc. 370.0519 m/z) and [Pt(N3)(triazole)]
+ (513.0912 m/z,
C16H10N6O2Pt, calc. 513.0513 m/z) were detected. MS/MS of the
[3–OH]+ 688.14 m/z ion gave identical daughter ions and
fragmentation behaviour to MS/MS of the [3 + H]+ (706.15 m/z)
species.
UV-Vis spectroscopy of 3 was consistent with partial loss of
a N3 → Pt LMCT band, with λmax moving to shorter wave-
lengths, from 299.5 nm (1) to 261.5 nm (3) (Fig. S7†). IR spec-
troscopy of a freshly prepared d4-MeOH sample of 3 (Fig. S8†)
showed the strong νasymN3 stretch at 2048 cm
−1 was slightly
weaker compared to the starting diazido complex 1
(2051 cm−1, solid)21 but similar to the value we reported for
the cyclometallated mono triazole DMAD complex trans,trans,
trans-[Pt(N3)(C5H3N3O4)(OH)(py)2] at 2046 cm
−1 (solid).11
Interconversion kinetics of 3a/3b
The kinetics of the 3a/3b equilibrium were investigated via
selective saturation-transfer experiments on interconverting 1H
NMR spectroscopic signals at 6.94 ppm (3bPhmeta) and
7.28 ppm (3aPhmeta) in d3-MeCN.
22 Data was acquired at 9
temperature points; the final values for the thermodynamic
parameters were calculated using an Eyring plot (Fig. S9†):
ΔG‡ = 76 (1) kJ mol−1 (at 298 K); ΔS‡ = −173 (4) J mol−1 K−1,
and ΔH‡ = 25 (1) kJ mol−1 (error in brackets). The exchange
rate constant k was determined as 0.28 s−1 (298 K), consistent
with similar processes.23 The negative entropic change is con-
sistent with cyclisation of 3a to 3b. We were unable to find
reports of any directly comparable systems involving cyclisa-
tion of a ligand which is attached to a Pt centre, rather than
bond breaking/formation at the metal centre itself. However,
the activation barrier appears to be in the appropriate range
for a reversible transformation at a metal centre on the NMR
timescale, and values reported for reversible bond formation
and breakage at a PtIV centre24 and rotation of a PtII–allene
complex25 are consistent with our findings.
Photochemistry of 3
A solution of 3 and 5′-GMP (5 equiv.) in phosphate-buﬀered
saline (PBS) solution was irradiated with UVA light and the
reaction monitored by LCMS (Fig. 3). Photochemically-induced
azide release was observed, through detection of the [3–N3]
+
fragment (663.16 m/z) in the mass spectrometer. The identity
of this main photoproduct was confirmed by HRMS (663.1318
m/z measured, C26H22N5O4Pt, calc. 663.1325 m/z, Fig. S11†).
The photochemistry of 3 was also investigated by 195Pt NMR
spectroscopy in d3-MeCN. Following irradiation (452 nm, 1 h),
new PtIV signals were observed, but no new 195Pt signals were
observed in the PtII region of the spectrum. This supports the
hypothesis that upon irradiation, 3 does not form PtII photo-
products, unlike for the precursor diazido complex 1 which
forms a variety of photoproducts, including PtII species. We
previously reported a range of adducts formed when 1 is irra-
diated in the presence of 5′-GMP.19 In contrast, when complex
3 was irradiated in the presence of 5′-GMP, no adducts were
detected by ESI-MS. PtIV diazido complexes have demonstrated
evolution of azidyl and hydroxyl radicals under irradiation,
which is thought to contribute to their potent photocytotoxic
eﬀects.26–28 EPR experiments in nitrogen-saturated MeCN solu-
tions confirmed production of azidyl radicals under blue light
irradiation (440–480 nm) by trapping with DMPO to form the
DMPO–N3
• adduct, which quickly built up a steady-state
Fig. 2 1H–195Pt HMBC NMR (proton at 500 MHz) spectrum of complex
3 in d3-MeCN, showing the presence of two isomers 3a and 3b.
Fig. 3 Irradiation of 3 (detected by ESI-MS predominantly as [3–OH]+)
in the presence of 5’-GMP with UVA irradiation in PBS solution; resulted
in photorelease of N3 and formation of [3–N3]
+, as monitored by HPLC.
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concentration of 18 µM, and then decayed on further illumina-
tion. This is consistent with our previous results from
irradiation of PtIV azido complexes.27 Although no hydroxyl
radicals were detected through trapping with DMPO to form
DMPO–OH•, small quantities (4 µM) of a stable non-coupled
nitroxide species was formed on a timescale significantly
slower than the formation of DMPO–N3
•. It was not detected
when DMPO alone was irradiated in nitrogen-saturated MeCN.
It is known that azide spin-adducts can themselves be trans-
formed via SN1 chemistry into other secondary species;
29
further investigation is ongoing (Fig. S12–S14†).
Experimental
For materials, methods and procedures see ESI.†
Conclusions
The PtIV mono azido mono triazolato complex product
(complex 3) of the reaction between 1 and 2, has been fully
characterised. To the best of our knowledge, the isomer 3b is
the first reported X-ray crystal structure of a Pt(IV) mono azido
complex. In MeCN, complex 3 exists as an equilibrium mixture
of open 3a and cyclised 3b isomers in 50 : 50 ratio; the thermo-
dynamics of this interconversion are consistent with ring-
opening and closing. Complex 3 can be photoactivated with
UVA (365 nm) and visible (452 nm) light in solution to give
[PtIV–N3]
+ as the main photoproduct, as determined by
ESI-MS. EPR experiments of an MeCN solution of 3 under
irradiation (440–480 nm) confirmed production of azidyl rad-
icals through spin-trapping with DMPO, as seen previously for
the precursor diazido species 1. No OH radicals were trapped
when 3 was irradiated, consistent with a [3–N3]
+ species being
the major photoproduct.
We did not detect photoejection of the triazole ligand from
the Pt centre of 3 in any of our irradiation experiments, poss-
ibly due to the additional stability aﬀorded by cyclisation of
the biphenyl ligand, resulting in bidentate coordination. MS/
MS studies of 3 also confirmed the strong binding of the tri-
azole ligand. Irradiation of 3 in the presence of the DNA
model 5′-GMP with either UVA or 452 nm light did not
produce any detectable 5′-GMP-Pt products.
The photocytotoxic mechanisms of diazido complexes such
as 1 are complicated, since azidyl radicals, hydroxyl radicals,
1O2, various DNA-binding Pt
IV and PtII fragments can be pro-
duced upon irradiation.28 The relatively simple photochemistry
observed for complex 3 may enable us to better understand the
photocytotoxic role and relative importance of the azidyl
radical when released in cellulo – these photobiological experi-
ments are ongoing. Such azidyl-releasing complexes in the
same line as photoCORMS (CO-releasing)30 and NORMS
(NO releasing)31 complexes may find application as photo-
therapeutics since azidyl radicals and azide anions are
cytotoxic; one pathway by which azidyl radicals may exert their
cytotoxic activity is via oxidative attack of tryptophan residues
in proteins;28 and sodium azide inhibits cytochrome oxidase
in the mitochondrial electron transport chain causing cell
death.32
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